ENT Devices – Market Insights – Asia Pacific

The Asia Pacific ENT device market saw a severe short-term impact from the COVID-19 pandemic in 2020 as many ENT procedures were delayed or canceled. Although the market rebounded in 2021 and 2022, owing to the recovery of deferred procedures, the pace of market growth was hindered by competition from nonsurgical alternative treatments, such as antibiotics. However, as the COVID-19 situation stabilizes, there will be increasing adoption of innovative and premium-priced products, such as flexiblescopes, RF handpieces, and powered instruments; as a result, the Asia Pacific market for ENT devices will grow at a modest pace following the impact of the pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in the Asia Pacific region from 2019 through 2031.

The COVID-19 pandemic has affected the ENT device market.

How have the countries covered fared through the COVID-19 pandemic?

How were different ENT procedures impacted across the Asia Pacific region, and what are the recovery trends for affected procedures?

How have capital equipment sales been affected?

ENT procedure volumes will grow modestly over the forecast period.

Which procedures will see the greatest growth through 2031? What factors will drive this growth?

What are procedure penetration trends for different procedures?

Limited patient awareness of and access to ENT procedures hinders procedure penetration in the emerging Chinese and Indian markets.

What factors are driving adoption of ENT procedures and devices in the Asia Pacific region?

Which segments of the ENT device market generate the most revenues in the countries covered, and which will expand the fastest going forward?

Most market segments are dominated by MNCs.

Which companies are the leading competitors in these markets, and what are their marketing strategies?

In which segments do local competitors play a strong role?

Table of contents

ENT Devices - Market Insights - Asia Pacific

Contact sales Login to access report

Back to all Medtech Insights reports